A phase I/II study of arfolitixorin and 5-fluorouracil in combination with oxaliplatin (plus or minus bevacizumab) or irinotecan in metastatic colorectal cancer-Reference-Cited by-同舟云学术

A phase I/II study of arfolitixorin and 5-fluorouracil in combination with oxaliplatin (plus or minus bevacizumab) or irinotecan in metastatic colorectal cancer

Published:2022-10 Issue:5 Volume:7 Page:100589
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Carlsson G.,Koumarianou A.,Guren T.K.,Haux J.,Katsaounis P.,Kentepozidis N.,Pfeiffer P.,Brændengen M.,Mavroudis D.,Taflin H.,Skintemo L.,Tell R.,Papadimitriou C.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference46 articles.

1. Diagnosis and treatment of metastatic colorectal cancer: a review;Biller;JAMA,2021

2. Cancer.Net. Colorectal Cancer: Statistics. Published 2021. Available at https://www.cancer.net/cancer-types/colorectal-cancer/statistics. Accessed October 8, 2021.

3. Colorectal cancer statistics, 2020;Siegel;CA Cancer J Clin,2020

4. American Cancer Society. Colorectal Cancer Facts & Figures 2020-2022. Published 2020. Available at https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/colorectal-cancer-facts-and-figures/colorectal-cancer-facts-and-figures-2020-2022.pdf. Accessed September 20, 2021.

5. Incidence and management of patients with colorectal cancer and synchronous and metachronous colorectal metastases: a population-based study;Väyrynen;BJS Open,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Randomized Phase III Study of Arfolitixorin versus Leucovorin with 5-Fluorouracil, Oxaliplatin, and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer: The AGENT Trial;Cancer Research Communications;2024-01-04